156eP Blood based immune-related biomarkers in patients with recurrent glioblastoma treated with nivolumab and bevacizumab (CA209-9UP)

20260 citationsJournal Articlegold Open Access

Authors

Good health and well-being

Published in: ESMO Open

Volume 11, pp. 106299-106299

Field-Weighted Citation Impact: 0.00